» Articles » PMID: 19478205

The I{kappa}B Kinase {beta}/nuclear Factor {kappa}B Signaling Pathway Protects the Heart from Hemodynamic Stress Mediated by the Regulation of Manganese Superoxide Dismutase Expression

Abstract

Cardiomyocyte death plays an important role in the pathogenesis of heart failure. The nuclear factor (NF)-kappaB signaling pathway regulates cell death, however, the effect of NF-kappaB pathway on cell death can vary in different cells or stimuli. The purpose of the present study was to clarify the in vivo role of the NF-kappaB pathway in response to pressure overload. First, we subjected C57Bl6/J mice to pressure overload by means of transverse aortic constriction (TAC) and examined the activity of the NF-kappaB pathway in response to pressure overload. IkappaB kinase (IKK) and NF-kappaB were activated after TAC. Then, we investigated the role of the activation using cardiac-specific IKKbeta-deficient mice (CKO). CKO displayed normal global cardiac structure and function compared with control littermates. We subjected CKO and control mice to pressure overload. One week after TAC, CKO showed cardiac dilation, dysfunction, and lung congestion, which are characteristics of heart failure. The number of apoptotic cells in the hearts of CKO mice increased significantly after TAC. The levels of manganese superoxide dismutase mRNA and protein expression in CKO after TAC were significantly attenuated compared with control mice. The levels of oxidative stress and c-Jun N-terminal kinase (JNK) activation in CKO after TAC were significantly greater than those in control mice. Isoproterenol-induced cell death of isolated adult CKO cardiomyocytes was inhibited by treatment with either a manganese superoxide dismutase mimetic or a JNK inhibitor. Thus, the IKKbeta/NF-kappaB signaling pathway plays a protective role in cardiomyocytes because of the attenuation of oxidative stress and JNK activation in a setting of acute pressure overload.

Citing Articles

NF-κB, A Potential Therapeutic Target in Cardiovascular Diseases.

Cheng W, Cui C, Liu G, Ye C, Shao F, Bagchi A Cardiovasc Drugs Ther. 2022; 37(3):571-584.

PMID: 35796905 DOI: 10.1007/s10557-022-07362-8.


NF-κB activation in cardiac fibroblasts results in the recruitment of inflammatory Ly6C monocytes in pressure-overloaded hearts.

Abe H, Tanada Y, Omiya S, Podaru M, Murakawa T, Ito J Sci Signal. 2021; 14(704):eabe4932.

PMID: 34637330 PMC: 11536391. DOI: 10.1126/scisignal.abe4932.


Fibroblast-specific IKK-β deficiency ameliorates angiotensin II-induced adverse cardiac remodeling in mice.

Lu W, Meng Z, Hernandez R, Zhou C JCI Insight. 2021; 6(18).

PMID: 34324438 PMC: 8492299. DOI: 10.1172/jci.insight.150161.


Cardiac Tissues From Stem Cells: New Routes to Maturation and Cardiac Regeneration.

Campostrini G, Windt L, van Meer B, Bellin M, Mummery C Circ Res. 2021; 128(6):775-801.

PMID: 33734815 PMC: 8410091. DOI: 10.1161/CIRCRESAHA.121.318183.


Guidelines for evaluating myocardial cell death.

Mishra P, Adameova A, Hill J, Baines C, Kang P, Downey J Am J Physiol Heart Circ Physiol. 2019; 317(5):H891-H922.

PMID: 31418596 PMC: 6879915. DOI: 10.1152/ajpheart.00259.2019.